1-2 of 2
J. Douglas Rizzo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer Registry

Sara J. Schonfeld, Bryan Valcarcel, Christa L. Meyer, Bronwen E. Shaw, Rachel Phelan, J. Douglas Rizzo, Ann Brunson, Julianne J. P. Cooley, Renata Abrahão, Ted Wun, Shahinaz M. Gadalla, Eric Engels, Paul S. Albert, Rafeek Yusuf, Stephen R. Spellman, Rochelle E. Curtis, Jeffery J. Auletta, Lori Muffly, Theresa H. M. Keegan, Lindsay M. Morton
Journal: Blood Advances
Blood Adv (2024) 8 (15): 4102–4112.
https://doi.org/10.1182/bloodadvances.2024012693
Published: 2024
Includes: Supplemental data
Journal Articles

Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial

Clinical Trials & Observations
Jennifer M. Knight, J. Douglas Rizzo, Parameswaran Hari, Marcelo C. Pasquini, Karen E. Giles, Anita D’Souza, Brent R. Logan, Mehdi Hamadani, Saurabh Chhabra, Binod Dhakal, Nirav Shah, Deepika Sriram, Mary M. Horowitz, Steve W. Cole
Journal: Blood Advances
Blood Adv (2020) 4 (3): 467–476.
https://doi.org/10.1182/bloodadvances.2019000765
Published: 2020
Includes: Supplemental data